Cost of Care for Juvenile Idiopathic Arthritis
Status: | Completed |
---|---|
Conditions: | Arthritis |
Therapuetic Areas: | Rheumatology |
Healthy: | No |
Age Range: | Any |
Updated: | 1/19/2018 |
Start Date: | January 2012 |
End Date: | March 2017 |
This project seeks to collect data on healthcare utilization and expenditure rates in
Juvenile Idiopathic Arthritis (JIA) patients from across the US, correlate these costs with
disease activity and outcome measures and determine methods by which to reduce the economic
impact while improving outcomes.
Juvenile Idiopathic Arthritis (JIA) patients from across the US, correlate these costs with
disease activity and outcome measures and determine methods by which to reduce the economic
impact while improving outcomes.
SPECIFIC AIMS AND OBJECTIVES
The specific aims of this registry protocol are:
- To create and maintain a secure online database of patients with JIA
- To collect data elements related to cost of care in patients with JIA
- Compare standard outcome and disease activity measures to health care expenditures in
JIA
- To determine methods by which to reduce costs while improving outcomes and quality of
care
The study plans to enroll 300 or more subjects from 3 medical centers in the US over a 24
month period. Subjects in the study are patients with Juvenile Idiopathic Arthritis.
Enrollment into the protocol will include key demographic and clinical data including,
medication exposures, disease severity, and function including disease-specific data
elements; and estimates of health care service utilization and health care expenditures. Data
will be collected once per subject within the context of a standard of care visit.
The specific aims of this registry protocol are:
- To create and maintain a secure online database of patients with JIA
- To collect data elements related to cost of care in patients with JIA
- Compare standard outcome and disease activity measures to health care expenditures in
JIA
- To determine methods by which to reduce costs while improving outcomes and quality of
care
The study plans to enroll 300 or more subjects from 3 medical centers in the US over a 24
month period. Subjects in the study are patients with Juvenile Idiopathic Arthritis.
Enrollment into the protocol will include key demographic and clinical data including,
medication exposures, disease severity, and function including disease-specific data
elements; and estimates of health care service utilization and health care expenditures. Data
will be collected once per subject within the context of a standard of care visit.
Inclusion Criteria:
- Subject has been diagnosed with JIA by a pediatric rheumatologist according to
published criteria.
- Person providing consent must be able to read English.
- Subject (and/or parent/legal guardian) is able to provide informed consent and willing
to comply with study procedures.
Exclusion Criteria:
- Subject/ legal guardian is unwilling to provide consent, cannot read English, or does
not meet published criteria for JIA.
- Coexisting rheumatologic disorder
- Diagnosis of fibromyalgia
- Participation in a drug trial in the past 6 months.
We found this trial at
3
sites
Click here to add this to my saved trials
4900 Mueller Boulevard
Austin, Texas 78723
Austin, Texas 78723
(512) 324-0000
Dell Children's Medical Center of Central Texas Welcome to Dell Children
Click here to add this to my saved trials
Cleveland Clinic Cleveland Clinic is committed to principles as presented in the United Nations Global...
Click here to add this to my saved trials